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Abstract 
Objective: We aimed to develop a goal classification of Individualised goals for spasticity 
treatment incorporating botulinum toxin intervention for upper limb spasticity to under-pin a 
more structured approach to future goal setting. 
 
Design: Individualised goals for spasticity treatment incorporating botulinum toxin 
intervention for upper limb spasticity (n=696) were analysed initially from four studies 
published in 2008-2012), spanning a total of 18 centres (12 in the UK and 6 in Australia). 
Goals were categorised and mapped onto the closest matching domains of the WHO 
International Classification of Functioning. Confirmatory analysis included a further 927 
goals from a large international cohort study spanning 22 countries published in 2013. 
 
Results: Goal categories could be assigned into two domains, each subdivided into three key 
goal areas:  
 Domain 1: Symptoms/impairment n=322 (46%): a. pain/discomfort n=78 (11%), b. 
involuntary movements n=75 (11%), c. range of movement/contracture prevention 
n=162 (23%). 
 Domain 2: Activities/function n=374 (54%): a. passive function (ease of caring for the 
affected limb) n=242 (35%), b active function (using the affected limb in active tasks) 
n=84 (12%), c. mobility n=11 (2%). 
Over 99% of the goals from the large international cohort fell into the same six areas, 
confirming the international applicability of the classification. 
  
Conclusions: Goals for management of upper limb spasticity, in worldwide clinical practice, 
fall into six main goal areas.  
 
Word count: 217 
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Introduction  
Spasticity is a common and distressing sequela of stroke, which interferes with upper limb 
movement and limits use of the limb for active functional tasks, as well as impacting on 
mobility and increasing the burden on caregivers 1.  Goals for treatment of upper limb 
spasticity are diverse, depending on the individual aspirations and priorities of the patient 
and/or their family. This diversity presents a challenge for outcome measurement in this 
context, due to the potential variety of outcome evaluation methods required to capture 
change in different domains. 
 
Goal attainment scaling is increasingly used as an outcome measure in clinical studies of 
spasticity intervention 2-6, but concerns have been raised about lack of standardisation in 
individual goal setting, which limits its comparability across different populations and 
settings 7, 8 .  The development of a simple goal classification for use in this context, may 
assist clinicians to use goal attainment scaling in a more timely and structured manner. The 
identification of a subset of standardised measures to be used alongside goal setting may 
also help to make outcome measurement more comparable. 
 
This short paper reports a secondary analysis of goal statements, rates of achievement and 
the measurement parameters that were used alongside them from five published studies 
that used goal attainment scaling as an outcome measure for treatment of upper limb 
spasticity using botulinum toxin 2, 4, 9, 10 6. 
 
Methods 
Our initial analysis included goal statements from four studies published between 2008 and 
2012: 
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1. Ashford and Turner-Stokes 2006: a small single centre, open label study from the UK 
recording the first published application of goal attainment scaling this context, 
(n=18, of which 9 had upper limb spasticity) 2. 
2. Ashford and Turner-Stokes 2008: a further small single centre, UK open label study, 
focussed on the use of botulinum toxin for management of shoulder girdle and 
proximal upper limb spasticity (n=16) 10. 
3. Turner-Stokes et al 2010: a secondary analysis of a multi-centre randomised 
controlled trial from Australia (n=90 patients from six centres)3, 4. 
4. Turner-Stokes et al 2013: the UK pilot for a large international prospective cohort - 
the Upper Limb International Spasticity (ULIS) series 6- incorporating n=151 patients 
from 12 centres 9. 
In all four studies, goals were set and systematically recorded using goal attainment scaling 
as described by Turner-Stokes 2009 11, based on the original method of Kiresuk and Sherman 
12.  These studies were selected based on the consistency of the goal setting process applied 
and the required recording of what goals were set. 
 
Goal statements were extracted from the datasets of all the four studies, and classified and 
mapped onto the WHO International Classification of Functioning (ICF) 13  with a view to 
reducing the number of goal categories to a smaller number of ‘key goal areas’. 
Classification of goals for studies 1 and 2 was undertaken by both authors (LTS and SA) 
independently and then compared, with any disagreements discussed and rectified. 
Classification of goals for studies 3 and 4 was taken from the existing datasets. In addition to 
the goal classification which was the primary aim of this work, we also interrogated the 
datasets for rates of goal achievement and also any parameters or standardised measures 
that had been used to provide quantification in goal evaluation (e.g. visual analogue scales, 
numerical rating scales etc.) within the different goal areas.  This information was not always 
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recorded and was not available for all data sets and is therefore preliminary evaluation at 
this stage. 
 
Confirmatory analysis of a further 927 goal statements from a large international cohort 
involving 84 centres in 22 countries (the ULIS-II study) published in 2013 6,  was undertaken 
to confirm or refute the goal classification.  
 
Results 
A total of 696 individualised primary and secondary goals for treatment of upper limb 
spasticity using botulinum toxin injection were analysed from the first four studies.  Goal 
classification is summarised in Table 1 with a list of measured goal parameters / 
standardised measures that were identified in each goal area. Overall 322 (46%) of goals 
were set in the domain of symptoms and impairment, whilst 374 (54%) goals were related to 
activities.  
Insert table 1 about here 
Key goal areas in the domain of ‘Symptoms and impairment’ were: 
 Reduction of spasticity-related pain (11%) 
 Prevention of contractures and deformity, by improving passive range of movement 
(23%). 
 Control of unwanted involuntary movements, such as associated reactions whilst 
walking or spasms (11%).  
Key goal areas in the domain of ‘Activities’ were: 
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 Making it easier to care for the affected limb (‘passive function’ 14) e.g. maintaining 
palmar/axillary hygiene, skin integrity, dressing the limb including splint application 
etc. (35%) 
 Using the affected limb for some purpose (‘active function’ 14) defined either by the 
motor task for function (e.g. grasping/holding/releasing objects, lifting and carrying 
or fine finger dexterity) (12%) – or by a functional task e.g. eating/drinking, household 
tasks, or activities related to work or hobbies (5%), or both. 
 Improved mobility - such as safer transfers, standing balance, improved walking (gait 
pattern, speed or endurance), confidence or reduction of falling/tripping (2%). 
Other goal areas that were used only occasionally related to improving body image (cosmesis) 
(1%) and facilitating therapy (0.01%) 
 
The analysis of goal areas reported in the fifth study 6 confirmed that that 99% of the goals 
fell into the same six areas. This supports the conclusion that our findings have saturated. 
Table 2 compares the distribution of goals set and achieved within each goal area and 
demonstrates the same goal categories in these two different data sets. Rates of 
achievement were generally higher in the fifth study, which may reflect the concerted 
approach to training in the use of goal attainment scaling that was taken in this study 6 
 
Discussion 
In this study, analysis of a total 1623 goals from five published studies led to the 
identification of 6 key goal areas in two principal domains, which were mapped on to the 
WHO ICF. Our analysis confirms that, despite their diversity, goals for management of upper 
limb spasticity fall broadly into six main goal areas.  
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The large number of goals analysed across 18 centres spanning two continents in our first 
analysis provided a firm basis for selection of the six key goal areas. The subsequent 
confirmatory goals analysis from the large international cohort involving 22 countries across 
four continents (the ULIS-II study) 6 supports the conclusion that our findings have saturated 
and have world-wide applicability. 
 
The findings have been used to inform the development of a structured approach to goal 
setting - the Goal Attainment Scaling – Evaluation of Outcome for Upper-limb Spasticity 
(GAS-eous) method, which is a structured process for applying goal attainment scaling 
alongside recording of standardised measures. This method and its development are 
described in an article in the International Journal of Therapy and Rehabilitation 15. 
 
The approach of identifying the common goal areas and associated subsets of standardised 
measures is by no means confined to the management of spasticity, but has the potential for 
wider application both in rehabilitation and in other areas of health and social care. In time 
this may lead to the establishment of ‘goal banks’ as recommended by Tennant 2007 8 
within the specific field of interest, that will further improve the utility and comparability of 
goal attainment scaling as a person-centred outcome measure for complex interventions. 
 
Word count 1086 
 
 
Clinical Messages 
 Two domains for goal setting could be consistently identified of ‘symptoms and 
impairment’ and ‘Activities’. 
 Six goal areas were identified, under the two domains; 1: Symptoms/impairment: pain, 
involuntary movements and range of movement.  2: Activities/function: passive function 
(ease of caring), active function (using the affected limb) and mobility. 
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Table 1: Breakdown of goals set (n=696) and standard measures in each goal area 
 
Goal Domain Goal area No. of goals 
set 
% of goals 
set 
Goal parameters / standard measures used* 
Symptoms and 
impairment 
N=322 goals (46%) 
Spasticity-related pain or discomfort 78 11% Visual analogues scales (VAS), numerical rating 
scales, Scale of Pain Intensity (SPIN) 16 
Involuntary movements during use of other 
limbs (associated reactions) or spasms 
75 11% Carry angle, spasm frequency, Associated 
Reaction Rating Scale (ARRS) 17 
Range of movement, prevention of 
contractures/ deformity, splint tolerance,  
162 23% Goniometry, anatomical distances (e.g. finger-
palm), splint tolerance times 
Activities  
N=374 goals (54%) 
Passive function - Ease of caring for the 
affected limb  
(e.g. maintaining hygiene, skin integrity, 
dressing the limb) 
242 35% Ease of care ratings (VAS or numerical rating), 
carer burden, time to complete task 
Arm Activity measure (ArmA) – passive function 
18-20 
Active function  -  
Domestic and community tasks 
(e.g. meal preparation, household duties, 
work-related tasks, recreation/leisure 
activities) 
 
Using the limb in an active function task  
(e.g. incorporating reaching, holding, 
grasping/releasing  objects, lifting and 
carrying, or fine dexterity) 
120 17% Ability to complete the defined task, Time taken, 
control/quality of movement 
Arm Activity measure (ArmA) – active function 18-
20 
Improved mobility ** 
(e.g. transfers, standing, walking, balance, 
confidence, avoiding falls) 
11 2% Gait speed (e.g. 10 metre walk), endurance (e.g. 6 
minute walk), video, falls frequency, confidence 
rating 
Therapy facilitation and cosmesis - perception 
of body image 
8 1%  
*All standardised measures or ordinal scales used to quantify goal attainment are indicated.  These measures were inconsistently applied in the four 
primary studies analysed in the goals analysis and in many cases were not used.  Data for goal parameter use were not available for all studies. 
**Goals for upper limb intervention related to improved mobility reflect the impact of the spastic upper limb on mobility 
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Table 2. Proportion of goals set and achieved in the different goal areas 
 
Goal Domain Goal area Combined analysis of 696 goals Analysis of the 927 goals from ULIS-II 
  No. of goals set No goals achieved No. of goals set No goals achieved 
Symptoms and 
impairment 
 
Pain  78 66 (85%) 145 121 (83%) 
Involuntary movements  75 51 (65%) 97 77 (79%) 
Impairment 162 95 (59%) 222 173 (78%) 
Activities  
 
Passive function  
 
242 
 
 
151 (62%) 241 197 (82%) 
Active function   
 
120 32 (27%) 182 122 (67%) 
Mobility  
 
11 6 (54%) 29 21 (72%) 
Other 8 7 (87%) 8 6 (75%) 
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